Rotavirus Vaccine: What Are The Risks?

The rotavirus vaccine is generally considered safe and effective at preventing rotavirus, a common and highly contagious infection that causes diarrhoea and vomiting. However, as with any medicine, there are some risks and side effects associated with the vaccine. The most common side effects include mild and temporary diarrhoea, vomiting, and irritability, which usually resolve on their own. More rarely, the vaccine has been linked to a small increased risk of intussusception, a rare type of bowel blockage. This side effect occurs in about 1 out of every 100,000 infants vaccinated, and prompt treatment can lead to a full recovery. Other contraindications include a history of severe allergic reactions, immune system disorders, and bowel problems. Overall, the benefits of the rotavirus vaccine are believed to outweigh the risks, and it is recommended for infants to protect against the potentially serious consequences of rotavirus infection.

Intussusception

Before the rotavirus vaccine was introduced in the United States, approximately 1,900 infants developed intussusception before their first birthday. The first rotavirus vaccine, RotaShield, was withdrawn from the market due to an increased risk of intussusception, which occurred in about 1 out of every 10,000 to 30,000 doses.

The risk of intussusception with the current rotavirus vaccines, RotaTeq and Rotarix, is estimated to be between 1 in 20,000 to 1 in 100,000 vaccinated infants. This risk is significantly lower than that associated with RotaShield. The majority of cases occur after the first dose, and the risk is highest within the first week of receiving the vaccine.

The symptoms of intussusception include severe stomach pain, crying, vomiting, blood in the stool, and the baby pulling their legs up to their chest. With prompt treatment, almost all infants with intussusception fully recover. Treatment typically involves a radiologist using air or fluid to push the folded part of the bowel back into place, although surgery may be required in about a third of cases.

Diarrhea and vomiting

The rotavirus vaccine can cause mild and temporary diarrhea and vomiting as side effects in some babies. These side effects usually go away on their own and are not a cause for concern. However, if your baby experiences persistent diarrhea and vomiting after receiving the vaccine, it is important to monitor them for signs of dehydration, such as reduced urination. In such cases, it is advisable to contact your healthcare provider for guidance.

In rare cases, the rotavirus vaccine has been associated with prolonged diarrhea and positive rotavirus antigen in stool samples. This raises questions about the potential impact of the vaccine on immune system function. However, it is important to note that the source of the rotavirus infection in these cases could not be conclusively determined.

It is recommended to wait until your baby is feeling better before administering the rotavirus vaccine if they have a high temperature, diarrhea, or vomiting. This precaution helps ensure your baby's comfort and reduces the potential for adverse reactions.

While the rotavirus vaccine has been linked to a very small risk of intestinal blockage (intussusception), this side effect is rare and occurs in approximately 1 out of every 100,000 infants. The benefits of the rotavirus vaccine in preventing severe diarrhea and vomiting caused by rotavirus infection clearly outweigh the risks associated with the vaccine.

Allergic reactions

If your baby has had a serious allergic reaction to a previous dose of the rotavirus vaccine, you should consult your healthcare provider before proceeding with subsequent doses. It is important to inform your healthcare professional if you or your child has any known allergies, including allergies to foods, dyes, preservatives, or animals.

In addition, individuals with a history of severe combined immunodeficiency disease (SCID), a rare condition affecting the immune system, are advised not to receive the rotavirus vaccine. SCID is an inherited disease, and individuals with a history of this condition should refrain from taking the vaccine.

Furthermore, those who have previously experienced intussusception, a rare type of bowel blockage, or have underlying bowel conditions that increase the risk of intussusception, are generally advised to avoid the rotavirus vaccine. Intussusception is an uncommon but painful intestinal blockage where the bowel or intestine folds into itself like a telescope.

While allergic reactions to the rotavirus vaccine are uncommon, it is important to be aware of the potential risks and consult with healthcare professionals to make an informed decision regarding vaccination.

Fructose intolerance

The rotavirus vaccine is considered very safe and effective at preventing rotavirus. Like any medicine, it can have side effects, but these are usually mild and temporary, and serious side effects are rare. The most common side effects include irritability, mild diarrhea, and vomiting.

There is a small risk of a rare type of bowel blockage called intussusception, which occurs when the bowel folds in on itself like a telescope. This condition is treatable, and babies typically make a full recovery. The rate of intussusception in those who received the vaccine is estimated to be about 1 in 100,000 infants, similar to the natural rate.

Now, addressing your specific concern about fructose intolerance:

Hereditary Fructose Intolerance:

Hereditary fructose intolerance is a genetic disorder caused by a mutation in the ALDOB gene, which results in a reduction of the aldolase B enzyme's function. This enzyme is responsible for breaking down fructose in the liver and converting it into usable energy. Without this enzyme, fructose accumulates in the body, leading to potential health complications.

Symptoms of hereditary fructose intolerance typically appear in infancy when fructose-containing foods are introduced. These symptoms can include nausea, bloating, abdominal pain, diarrhea, vomiting, and low blood sugar (hypoglycemia). Continued exposure to fructose can lead to more severe complications such as liver and kidney damage, seizures, coma, and even organ failure. Repeated ingestion of fructose can result in chronic liver disease (cirrhosis).

Dietary Fructose Intolerance (Fructose Malabsorption):

Dietary fructose intolerance, also known as fructose malabsorption, occurs when the cells in the intestines cannot absorb fructose properly. This condition typically develops in adults and is characterized by symptoms similar to irritable bowel syndrome (IBS) when consuming foods with high fructose content. These symptoms may include bloating, diarrhea or constipation, flatulence, and stomach pain.

It is important to note that infants with hereditary fructose intolerance may be at an increased risk of adverse effects if they receive the rotavirus vaccine. Please consult your healthcare provider for personalized advice and to determine if your child has any contraindications to the rotavirus vaccine, including fructose intolerance.

Severe combined immunodeficiency disease (SCID)

Severe combined immunodeficiency (SCID) is a rare genetic disorder that causes life-threatening problems with the immune system. SCID is caused by mutations in different genes involved in the development and function of immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections. The condition is fatal, usually within the first year or two of life, unless infants receive immune-restoring treatments.

SCID causes babies to be born with little to no immune system. This means that common, usually mild infections can be fatal because their bodies don't have a strong enough natural defence system. The immune system doesn't work as it should, so it's hard or impossible for it to battle the germs (viruses, bacteria, and fungi) that cause infections. SCID is characterised by a lack of T-cells, which are critical for B-cells to function, so babies with SCID will also have problems with the types of infections B-cells are supposed to handle.

There are different types of SCID, depending on which immune cells the child is missing. The most common type is autosomal recessive SCID, caused by adenosine deaminase (ADA) deficiency, in which infants lack the ADA enzyme necessary for T-cell survival. Another form, X-linked SCID, is caused by mutations in a gene on the X chromosome and primarily affects male infants. Boys with this type of SCID have abnormal white blood cell growth and development, resulting in low numbers of T cells and natural killer cells, and non-functioning B cells.

SCID can be successfully treated if it's found early. Newborn screening for SCID has been introduced, and this early diagnosis has boosted the five-year survival rate of children with the disorder from 73% before screening to 87% since. The standard treatment for infants with SCID is a stem cell (bone marrow) transplant, ideally from a sibling with a close tissue match. Other treatments include gene therapy and enzyme therapy.

Frequently asked questions